The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death.
There are no additional interventions regarding this registry.
diagnosis of interstitial lung disease
written informed consent
to not comprehend and rightfully judge participation
Everybody with a diagnosis of interstitial lung disease, over 18 years old will be asked to participate.
Cohort
Other
Not listed
Mortality
Mortality caused by interstitial lung disease
Loss of lung function
FVC and DLCO loss within 24 months
Prevalence
Prevalence of the different interstitial lung diseases in Austria
Response to drugs
Response to immunosuppressive/immunomodulating/antifibrotic drugs
Click on the lead sponsor to view all of their trials.
